Surprise, Surprise – UK Medicine Regulator is funded by the Bill & Melinda Gates Foundation
MRHA awarded £980,000 from BMGF.
So Bill Gates who wants to depopulate the world through so-called vaccines gives money to the regulatory body that approves UK vaccines and which keeps track of adverse effects with its Yellow Card Database - then MHRA goes on the defensive when people die after being jabbed with a toxin.
UK's medicine regulator receives funding from the Bill & Melinda Gates Foundation that pushes vaccines and depopulation
The UK’s Medicines and Healthcare products Regulatory Agency, or MHRA, is meant to be a neutral body that is responsible for making sure that the medicine and medical devices used in the country are acceptably safe.
However, there are serious questions about the agency’s impartiality because they receive significant funding from the Bill & Melinda Gates Foundation in what can only be considered a major conflict of interest. The foundation holds major shares in COVID-19 vaccine developers Pfizer and BioNTech.
Perhaps this explains why the Pfizer and BioNTech vaccine was the first one to be authorized for use in children aged 12 and over back in June and remained the only one available to this age group until Moderna’s vaccine was approved this week.
The approval of Pfizer’s vaccine was particularly shocking when you consider that 86 percent of children who participated in the very short and small clinical study used to make the decision suffered from an adverse reaction.
In a Freedom of Information request posted on the website of the MHRA, a representative of the agency admitted that they do receive funding from the Bill and Melinda Gates Foundation that mainly supports work on strengthening the regulatory systems in other countries. They added that most of their income comes from fees paid by the pharmaceutical industry.
The agency stated that the current level of grant funding that they receive from the foundation is roughly $3 million, which they say is spread across several projects and three to four financial years.
They added that they would not approve any COVID-19 vaccines until they demonstrate “safety, quality and efficacy through a robust clinical trial programme, as determined by the MHRA, and unless the evidence supports its use.” However, they go on to add that they carefully reviewed the clinical trial data for Pfizer’s vaccine in a study of just 2000 children. They said that the safety data in children was on par with that seen in young adults, which is hardly comforting.